XML 15 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows from Operating Activities:    
Net income (loss) $ (8,861) $ 7,379
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation expense 149 245
Non-cash stock compensation expense 1,452 314
Non-cash lease expense 92 74
Non-cash interest expense 39 34
Change in fair value of warrant liabilities (7,643) (14,881)
Accretion of debt discount 306 44
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (1,260) 167
Other assets (21) 5
Accounts payable 1,698 507
Accrued expenses (3,858) (2,368)
Deferred income (22)  
Lease liability (108) (136)
Net cash used in operating activities (18,037) (8,616)
Cash Flows from Investing Activities:    
Purchase of fixed assets (675) (3)
Net cash used in investing activities (675) (3)
Cash Flows from Financing Activities:    
Proceeds from option exercises 28 246
Principal payments on term loan   (2,500)
Net cash provided by (used in) financing activities 93,815 (1,870)
Net increase (decrease) in cash, cash equivalents and restricted cash 75,103 (10,489)
Cash, cash equivalents and restricted cash at beginning of period 120,147 102,920
Cash, cash equivalents and restricted cash at end of period 195,250 92,431
Supplemental cash flow information:    
Cash paid for interest 1,222 252
Supplemental disclosures of non-cash information:    
Issuance costs in accounts payable and accrued expense 299 (25)
Capital expenditures in accounts payable and accrued expenses 39 16
At-the-Market Offering [Member]    
Cash Flows from Financing Activities:    
Proceeds from sale of common stock through at-the-market offerings, net of issuance costs   $ 384
Public Offering [Member]    
Cash Flows from Financing Activities:    
Proceeds from issuance of common stock in public offering, net of issuance costs $ 93,787